MedTrace Logo

Explanation About Sleep in Post Trauma Patients

NCT01684085 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 70

Last updated 2012-10-10

No results posted yet for this study

Summary

This study is designed to test the effect of an explanation about the first sleep following trauma exposure, on the development of Post Traumatic Stress Disorder (PTSD) in the months following the traumatic event.

Conditions

  • Post Traumatic Stress Disorder
  • Sleep Deprivation

Interventions

BEHAVIORAL

Explanation encouraging sleep

An explanation will be given about sleep, encouraging the patient to sleep - lorazepam 1mg will be offered to promote sleep.

BEHAVIORAL

Explanation discouraging sleep

An explanation about sleep will be given, discouraging the patient from sleeping in the first night after the traumatic event.

DRUG

Lorazepam

Lorazepam 1 mg

Sponsors & Collaborators

  • Sheba Medical Center

    lead OTHER_GOV

Principal Investigators

  • Joseph Zohar, MD · Department of Psychiatry, Chaim Sheba Medical Center, Israel

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-10-31
Primary Completion
2014-09-30

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01684085 on ClinicalTrials.gov